WARSAW, Ind., Aug. 13, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place in Boston.  Cole Lannum, CFA, Senior Vice President of Investor Relations, will present for the

WARRINGTON, Pa., Aug. 13, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation f

DENVER, Aug. 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), today announced that the Company will host a conference call to discuss operational and financial highlights from its second quarter 2019 on Thursday, August 15, 2019 at 4:15 p.m. ET

RANCHO CORDOVA, Calif., Aug. 13, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter ended June 30, 2019 and provided a corpor

IRVINE, Calif., Aug. 13, 2019 /PRNewswire/ -- NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, today announced that it has dosed the first subject in study SNK01-US01, a phase I clinical trial evaluating SNK, an ex vivo expanded autologous natural killer cell t

LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the second quarter ended June 30, 2019.

STATESVILLE, N.C., Aug. 13, 2019 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its first quarter fiscal year 2020 financial results on Tuesday, August 27, 2019 after the close of trading.  This information will be available on the Company's website

WAYNE, Pa., Aug. 13, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today reported financial results for the second quarter ended June 30, 2019 including net sales from commercial products: SPRIX® (ketorolac tromethamine) Nasal Spray, the SoluMatrix

MALVERN, Pa., Aug. 13, 2019 /PRNewswire/ -- Azura Vascular Care announced recently that, as part of a phased brand rollout, Capitol City Vascular Care will now be known as Azura Vascular Care Capitol City. Eugene Essandoh, MD, board certified in both internal medicine and nephrology, is the Medical Director of the established outpati

PORT WASHINGTON, N.Y., Aug. 13, 2019 /PRNewswire/ -- Sandata Technologies, LLC, the leading provider of technology solutions for the home care market, announced its partnership with CareConnect, a software solution provider revolutionizing how home care agencies manage, communicate, and optimize their existing caregiver pool. This newly formed partnership enables pr